CellAegis Devices Announces Initiation of Clinical Testing of Remote Ischemic ... MarketWatch (press release) The study design for the Toronto clinical program calls for the enrollment of 24 adult patients with stage T1 renal cell carcinoma (RCC) scheduled to undergo partial nephrectomy. Patients will be randomized 1:1 to either a) a treatment group receiving ... |
